DEXCOM INC is 20.9x more valuable than AtriCure, Inc. by market capitalization ($28.85 B vs $1.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATRC | DXCM |
|---|---|---|
| Market cap | $1.38 B | $28.85 B |
| US-listed rank | #2394 | #473 |
| Revenue (latest FY) | $534.53M | $4.66B |
| Net income (latest FY) | -$11.45M | $836.30M |
| Net margin | -2.1% | 17.9% |
| P/E (trailing FY) | - | 34.5 |
| SEC filings | 1,531 | 2,566 |
DEXCOM INC is 20.9x more valuable than AtriCure, Inc. by market capitalization ($28.85 B vs $1.38 B).
In their latest fiscal years, AtriCure, Inc. reported $534.53M in revenue while DEXCOM INC reported $4.66B.
Full pages: AtriCure, Inc. and DEXCOM INC, or browse the full rankings.